Syngene International

The new OEB-5 rated suite will enable end-to-end antibody-drug conjugate (ADC) services from discovery to GMP manufacturing at a…

New Bengaluru peptide laboratory and automation upgrades in Hyderabad aim to improve scalability, efficiency, and data quality

Alok Mehrotra, Chief Quality Officer, Syngene International presented a session on 'Audit-proof pharma: Creating a culture of…

The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development,…

Jonathan Hunt steps down as MD & CEO; Board announces leadership transition

The programme featured a curriculum-aligned question bank incorporating real-world scenarios with the aim of fostering critical…

Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…

30 women from tier 2 and 3 institutions have been selected for the second cohort of the program

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million…

The acquisition of the ‘Unit 3’ biologics manufacturing facility was concluded at a revised gross value of Rs 617 crores adjusted…